Skip to content

Interest in Electronic Applications for Patients With Glaucoma

Interest of Patients and Their Caregivers in A Smartphone- and Tablet-Based Application for Patients With Glaucoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02659709
Acronym
GlaucomaApp
Enrollment
50
Registered
2016-01-20
Start date
2015-06-30
Completion date
2016-10-31
Last updated
2019-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Glaucoma, Smartphone, Tablet, Application, Eye Drops

Brief summary

To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.

Detailed description

This study is designed to determine the amount of interest in an educational application (app) on social media for glaucoma patients and their caregivers. The purpose of this App is to enhance understanding of glaucoma by using short video tutorials. The App will include glaucoma eye drop medication reminders, a short video tutorial which aims to improve understanding of how visual field testing should be performed, how to administer eye drops and a feature that will enable participants to store and organize testing results using a mobile device.

Interventions

DEVICEInterest in medical education through social media

Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.

Sponsors

Wills Eye
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Anyone affected by glaucoma * Family and friends of someone with glaucoma

Exclusion criteria

* unable to complete survey

Design outcomes

Primary

MeasureTime frameDescription
Patients Owning Smartphone/Tablet Technology1 hourResponses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Patients Having Access to Social Media Via Smartphone or Tablet in the Home1 hourResponses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

Secondary

MeasureTime frameDescription
Glaucoma Medication Compliance1 hourResponses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
Use of Medication Reminder1 hourResponses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.

Countries

United States

Participant flow

Recruitment details

Glaucoma patients and Caregivers were recruited from the Glaucoma Service at Wills Eye Hospital, Philadelphia, PA, USA.

Participants by arm

ArmCount
Glaucoma Patients and Caregivers
50 Glaucoma patients and/or caregivers will test a glaucoma application (app) on smart phones or tablets then complete a 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
50
Total50

Baseline characteristics

CharacteristicGlaucoma Patients and Caregivers
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
17 Participants
Age, Categorical
Between 18 and 65 years
32 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
9 Participants
Race (NIH/OMB)
More than one race
3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
33 Participants
Region of Enrollment
United States
50 participants
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
18 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 50
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Patients Having Access to Social Media Via Smartphone or Tablet in the Home

Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

Time frame: 1 hour

Population: Participants responding Yes to anyone in the house owning a smartphone or tablet.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glaucoma Smartphone ApplicationPatients Having Access to Social Media Via Smartphone or Tablet in the Home39 Participants
Primary

Patients Owning Smartphone/Tablet Technology

Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

Time frame: 1 hour

Population: Participants responding Yes to owning a smartphone or tablet.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glaucoma Smartphone ApplicationPatients Owning Smartphone/Tablet Technology34 Participants
Secondary

Glaucoma Medication Compliance

Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.

Time frame: 1 hour

Population: Participants responding Yes using their glaucoma eye drops as prescribed.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glaucoma Smartphone ApplicationGlaucoma Medication Compliance25 Participants
Secondary

Use of Medication Reminder

Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.

Time frame: 1 hour

Population: Participants responding Yes to using their glaucoma eye drops as prescribed without reminders.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glaucoma Smartphone ApplicationUse of Medication Reminder28 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026